Novavax Begins Early Stage Clinical Study of Its Coronavirus Vaccine Candidate
The biotech hopes to announce results from the phase 1 part of the clinical study in July.
Full Article
Novavax Begins Early Stage Clinical Study of Its Coronavirus Vaccine Candidate
Motley Fool
0 shares
1 views
You might like
Related news coverage
Dow leaps 530 points as hopes for a smooth reopening gain traction
Business Insider
**
· *US stocks surged through Tuesday trading as investors' optimism toward economic reopenings overshadowed flaring..
Dow rockets 600 points as optimism grows around economic reopenings
Business Insider
Advertisement
More coverage
The untold story of Moderna as the biotech's coronavirus vaccine faces a test that could make it one of the most consequential startups of all time (MRNA)
Business Insider
· The biotech Moderna has skyrocketed to global prominence, leading the world's race for a coronavirus vaccine.
· The..
UK's COVID-19 study aims to vaccinate more than 10,000
SeattlePI.com